AvatarALflipped into Bio Science & MedStoryboardI Ignored It...: The Unexpected Symptoms That Uncovered My Bladder CancerAvatarCurated byFOODIELIFEForget the burning! Discover the surprising symptom I ignored that led to a bladder cancer diagnosis.
AvatarSeeking Alphaflipped into Breaking NewsAvatarAvatar3 hours ago4D Molecular slips after regulatory update on lead assetverified_publisherSeeking Alpha - Dulan Lokuwithana4D Molecular Therapeutics (NASDAQ:FDMT) lost ~8% on Thursday after the gene therapy developer, following interactions with U.S. and EU regulators, …
AvatarInvestor's Business Dailyflipped into Financial & Business NewsFlipboardIcon version of the Flipboard logo1 hour agoWhy Cathie Wood's Darling Crispr Has Tumbled For Five Weeks Straightinvestors.com - ALLISON GATLINCrispr stock is tumbling for the fifth straight week as the top Cathie Wood's holding struggles amid dimming expectations for its new …
AvatarTipRanksflipped into TipRanks LabsFlipboardIcon version of the Flipboard logo3 hours agoBuy Rating Affirmed for Precision BioSciences on Promising Gene Editing Prospects and Strong Financialstipranks.com - Jason CarrPatrick Trucchio, an analyst from H.C. Wainwright, reiterated the Buy rating on Precision BioSciences (DTIL – Research Report). The associated price …
AvatarBioPharma Diveflipped into BioPharma DiveFlipboardIcon version of the Flipboard logo6 days agoFDA clears first-of-its-kind Duchenne drug for broad usebiopharmadive.com - Ben FidlerDive Brief:• The Food and Drug Administration on Thursday approved a first-of-its-kind drug for Duchenne muscular dystrophy, clearing Duvyzat, a …
AvatarPeak Bggrflipped into Biotech InvestingFlipboardIcon version of the Flipboard logo6 hours agoTaysha Gene Therapies (TSHA) Gets a Buy from Truist Financialtipranks.com - Austin AngeloTruist Financial analyst Joon Lee maintained a Buy rating on Taysha Gene Therapies (TSHA – Research Report) today. The company’s shares closed …
AvatarMike Jansonflipped into CRISPR FlipboardIcon version of the Flipboard logo1 day agoThe Role Of Behavioral Science In Improving Cell & Gene Therapy Adoptioncellandgene.com - Vertmarkets Inc.There is still a lot of work for cell and gene therapy developers to do to promote their uptake. How might behavioral science help?
AvatarInvestor's Business Dailyflipped into Financial & Business NewsFlipboardIcon version of the Flipboard logo2 hours agoHow This Sleeper Biotech, With A 687% Gain, Is Making A Comebackinvestors.com - ALLISON GATLINSolid Biosciences (SLDB) is shrugging off several messy years in gene therapy development, an analyst said Thursday as he initiated coverage of the …
AvatarPeak Bggrflipped into Biotech InvestingFlipboardIcon version of the Flipboard logoBoston biotech firm sets highest drug price tag in history: $4.25M per treatmentnbcboston.com - Hannah GreenOrchard Therapeutics made history this week when the U.S. Food and Drug Administration approved its gene therapy as the first treatment for children …
AvatarTipRanksflipped into TipRanks LabsFlipboardIcon version of the Flipboard logoTaysha Gene Therapies price target raised to $7 from $5 at Chardantipranks.com - TheFlyChardan analyst Geulah Livshits raised the firm’s price target on Taysha Gene Therapies to $7 from $5 and keeps a Buy rating on the shares. The …
AvatarSeeking AlphaAvatarAvatar1 hour agoWilliam Blair starts Solid Biosciences at outperformverified_publisherSeeking Alpha - Val Brickates KennedyWilliam Blair has initiated coverage of Solid Biosciences (NASDAQ:SLDB) with an outperform rating, citing its market opportunities in Duchenne …
AvatarPeak Bggrflipped into Biotech InvestingFlipboardIcon version of the Flipboard logo1 day agoGene therapy improves vision in patients with retinitis pigmentosa in phase 2b trialhealio.com - Anthony DeFinoMCO-010 demonstrated positive topline results in vision improvement in patients with permanent and severe vision loss from advanced retinitis …